COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,803 Articles (22,527 medRxiv, 8,276 bioRxiv)

Most recent first Previous |  Page 903: Articles 9021-9030  | Next

Working from home due to the COVID-19 pandemic abolished the sleep disturbance vulnerability of late chronotypes relieving their predisposition to depression
Salfi, F., D'Atri, A., Amicucci, G., Viselli, L., Gorgoni, M., Scarpelli, S., Alfonsi, V., Ferrara, M.
10.1101/2022.02.02.22270278 — Posted: 2022-02-04
Managing Endothelial Dysfunction in COVID-19: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial at the Lebanese American University Medical Center - Rizk Hospital (MEDIC-LAUMCRH)
Matli, K., Al Kotob, A., Jamaleddine, W., Al-Osta, S., Salameh, P., Tabbikha, R., Chamoun, N., Moussawi, A., Saad, J. M., Atwi, G., Abusaad, T., Jamal, O., Mokhbat, J., Ghanem, G.
10.1101/2022.02.02.22270341 — Posted: 2022-02-04
COMPARATIVE PERFORMANCE OF TWO AUTOMATED MACHINE LEARNING PLATFORMS FOR COVID-19 DETECTION BY MALDI-TOF-MS
Rashidi, H. H., Pepper, J., Howard, T., Klein, K., May, L., Albahra, S., Phinney, B., Salemi, M., Tran, N. K.
10.1101/2022.02.02.22270298 — Posted: 2022-02-04
Pediatric Croup during the COVID-19 Omicron Variant Surge
Tunc, E. M., Koid Jia Shin, C., Usoro, E., Thomas-Smith, S. E., Migita, R. T., Trehan, I., Keilman, A. E.
10.1101/2022.02.02.22270222 — Posted: 2022-02-04
Serious hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants: an exposed-unexposed cohort study in December 2021 from the COVID-19 surveillance databases in France
Auvigne, V., Vaux, S., Le Strat, Y., Schaeffer, J., Fournier, L., Montagnat, C., Coignard, B., Levy-Bruhl, D., Parent du Chatelet, I.
10.1101/2022.02.02.22269952 — Posted: 2022-02-04
Comparative evaluation of oral lesions: Tale - the Covid 19 Tells
Bhavasar, R. P., Ajith, N. A., Bhavasar, R. P., Dhawal, A., Vaswani, V.
10.1101/2022.02.03.22269712 — Posted: 2022-02-04
Transparency and reporting characteristics of COVID-19 randomized controlled trials.
Kapp, P., Esmail, L., Ghosn, L., Ravaud, P., Boutron, I.
10.1101/2022.02.03.22270357 — Posted: 2022-02-04
Efficacy and safety of nitazoxanide combined with ritonavir-boosted atazanavir for the treatment of mild to moderate COVID-19
Fowotade, A., Bamidele, F., Egbetola, B., Adefuye, B. O., Fagbamigbe, A. F., Adeagbo, B. A., Olagunoye, A., Ojo, T. O., Adebiyi, A. O., Olagunju, O. I., Ladipo, O. T., Akinloye, A., Onayade, A., Bolaji, O. O., Happi, C., Rannard, S., Owen, A., Olagunju, A.
10.1101/2022.02.03.22270152 — Posted: 2022-02-04
OraSure InteliSwab Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and Omicron
Weishampel, Z., Young, J., Fischl, M., Fischer, R., Owusu, I. O., Riopelle, J., Schulz, J., Port, J. R., Saturday, T., van Doremalen, N., Berry, J., Munster, V., Yinda, C. K.
10.1101/2022.02.02.22270254 — Posted: 2022-02-04
Equitable COVID-19 vaccine prioritization: front-line workers or 65-74 year olds?
Rumpler, E., Feldman, J. M., Bassett, M. T., Lipsitch, M.
10.1101/2022.02.03.22270414 — Posted: 2022-02-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).